Urolithiasis Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By End Use, By Region, and By Competition, 2020-2030F

Description

The Global Urolithiasis Management Devices Market, valued at USD 2.01 Billion in 2024, is projected to experience a CAGR of 4.97% to reach USD 2.69 Billion by 2030. Urolithiasis management devices encompass a range of medical instruments essential for the diagnosis, treatment, and prevention of kidney stones and other urinary tract calculi. This market experiences robust growth primarily driven by the increasing global prevalence of urolithiasis, coupled with a growing preference for minimally invasive surgical procedures that offer enhanced patient outcomes and reduced recovery times. Advancements in medical technologies, including sophisticated laser lithotripters and flexible ureteroscopes, further stimulate market expansion by providing more effective stone fragmentation and removal solutions.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.01 Billion
Market Size 2030	USD 2.69 Billion
CAGR 2025-2030	4.97%
Fastest Growing Segment	Intracorporeal Lithotripsy
Largest Market	North America

Key Market Drivers

The rising global burden of urolithiasis primarily drives the Global Urolithiasis Management Devices Market, with increasing prevalence expanding the patient population needing intervention. Shifting lifestyles, dietary habits, and metabolic disorders contribute to this growing caseload. According to "The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000-2021: a systematic analysis for the Global Burden of Disease Study 2021" via ResearchGate, in November 2024, there were 106 million incident cases of urolithiasis in 2021. This incidence ensures consistent demand for detection, treatment, and prevention instruments, stimulating market growth. The broader urology devices market reflects robust strategic investment; HealthLeaders Media reported in January 2024 that Boston Scientific acquired Axonics for $3.7 billion, underscoring significant financial commitments.

Key Market Challenges

The high cost associated with advanced urolithiasis management devices and surgical interventions presents a significant impediment to market growth. This financial burden directly restricts widespread adoption, particularly in developing regions where healthcare budgets are limited and patient out-of-pocket expenses are substantial. The investment required for advanced equipment, such as laser lithotripters and flexible ureteroscopes, can be prohibitive for many healthcare facilities. This limitation curtails the market penetration of innovative solutions, thereby reducing potential sales and usage in areas with a high prevalence of urinary tract calculi.

Key Market Trends

The increasing shift of urological procedures to Ambulatory Surgical Centers (ASCs) is a significant trend impacting the global urolithiasis management devices market. This trend is driven by the advantages ASCs offer, such as cost-effectiveness for patients and healthcare systems, shorter waiting times, and a more streamlined patient experience compared to traditional hospital settings. As procedures become less invasive and technological advancements facilitate outpatient care, more complex urological interventions, including certain stone removal procedures, are being safely performed in ASCs. According to a March 2025 report from MedPAC, the volume of ASC surgical procedures per fee-for-service Medicare beneficiary rose by 5.7 percent in 2023. This expansion directly influences device manufacturers to adapt their sales and distribution strategies to cater to the unique procurement and inventory management needs of ASCs, fostering demand for devices optimized for outpatient use.

Key Market Players

Allengers Medical Systems Ltd
Boston Scientific Corp
Cook Medical Inc
CONMED Corp
DiREX Group
Dornier MedTech GmbH
HealthTronics Inc
Karl Storz SE & Co KG
Lumenis Inc
Siemens Healthcare Ltd

Report Scope:

In this report, the Global Urolithiasis Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Urolithiasis Management Devices Market, By Treatment Type:

Extracorporeal Shock Wave Lithotripsy (ESWL)
Intracorporeal Lithotripsy
Percutaneous Nephrolithotomy
Others

Urolithiasis Management Devices Market, By End Use:

Hospitals & Clinics
Ambulatory Surgical Centers
Others

Urolithiasis Management Devices Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Urolithiasis Management Devices Market.

Available Customizations:

Global Urolithiasis Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Urolithiasis Management Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others)
- 5.2.2. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Urolithiasis Management Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Treatment Type
- 6.2.2. By End Use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Urolithiasis Management Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Treatment Type
    - 6.3.1.2.2. By End Use
- 6.3.2. Canada Urolithiasis Management Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Treatment Type
    - 6.3.2.2.2. By End Use
- 6.3.3. Mexico Urolithiasis Management Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Treatment Type
    - 6.3.3.2.2. By End Use

7. Europe Urolithiasis Management Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Treatment Type
- 7.2.2. By End Use
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Urolithiasis Management Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Treatment Type
    - 7.3.1.2.2. By End Use
- 7.3.2. France Urolithiasis Management Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Treatment Type
    - 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Urolithiasis Management Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Treatment Type
    - 7.3.3.2.2. By End Use
- 7.3.4. Italy Urolithiasis Management Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Treatment Type
    - 7.3.4.2.2. By End Use
- 7.3.5. Spain Urolithiasis Management Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Treatment Type
    - 7.3.5.2.2. By End Use

8. Asia Pacific Urolithiasis Management Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Treatment Type
- 8.2.2. By End Use
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Urolithiasis Management Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Treatment Type
    - 8.3.1.2.2. By End Use
- 8.3.2. India Urolithiasis Management Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Treatment Type
    - 8.3.2.2.2. By End Use
- 8.3.3. Japan Urolithiasis Management Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Treatment Type
    - 8.3.3.2.2. By End Use
- 8.3.4. South Korea Urolithiasis Management Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Treatment Type
    - 8.3.4.2.2. By End Use
- 8.3.5. Australia Urolithiasis Management Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Treatment Type
    - 8.3.5.2.2. By End Use

9. Middle East & Africa Urolithiasis Management Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Treatment Type
- 9.2.2. By End Use
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Urolithiasis Management Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Treatment Type
    - 9.3.1.2.2. By End Use
- 9.3.2. UAE Urolithiasis Management Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Treatment Type
    - 9.3.2.2.2. By End Use
- 9.3.3. South Africa Urolithiasis Management Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Treatment Type
    - 9.3.3.2.2. By End Use

10. South America Urolithiasis Management Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Treatment Type
- 10.2.2. By End Use
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Urolithiasis Management Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Treatment Type
    - 10.3.1.2.2. By End Use
- 10.3.2. Colombia Urolithiasis Management Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Treatment Type
    - 10.3.2.2.2. By End Use
- 10.3.3. Argentina Urolithiasis Management Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Treatment Type
    - 10.3.3.2.2. By End Use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Urolithiasis Management Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Allengers Medical Systems Ltd
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Boston Scientific Corp
15.3. Cook Medical Inc
15.4. CONMED Corp
15.5. DiREX Group
15.6. Dornier MedTech GmbH
15.7. HealthTronics Inc
15.8. Karl Storz SE & Co KG
15.9. Lumenis Inc
15.10. Siemens Healthcare Ltd